• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    TaiMed Biologics

    Federal Equipment Company

    LOTTE BIOLOGICS

    Syngene International Ltd.

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    TaiMed Biologics

    Federal Equipment Company

    LOTTE BIOLOGICS

    Syngene International Ltd.

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Eurofins to Acquire Amatsigroup for $150M

    Expands position in biopharmaceutical services

    Eurofins to Acquire Amatsigroup for $150M
    07.12.17
    Eurofins Scientific, a provider of biopharma products testing services, has signed an exclusive agreement with Ekkio Capital to acquire the Amatsigroup for approximately $150 million.

    Amatsigroup is a contract development and manufacturing organization (CDMO) providing preclinical and clinical phase services for the development of human and veterinary drugs. Founded in 2010 by Ekkio Capital, it was formed through the merger of four French companies—Avogadro, Amatsi, DBI and Avepharm—bringing complementary expertise and a cumulative experience in the field of over 30 years. As of 2014, Amatsigroup began to expand internationally with the acquisition of its subsidiaries SEPS Pharma in Belgium and Amatsigroup Inc. in Indiana. Its expansion continued in 2015 with the acquisition of Pierre Fabre's pharmaceutical analysis laboratory in Saint-Augustin, France. In 2016, the group expanded its activity through the acquisition of QBiologicals, a Belgian company specialized in bioprocess development & biomanufacturing. In early 2017, Amatsigroup strengthened its sterile capacities with the acquisition of Disposable Lab and even more recently signed an exclusive agreement to acquire two sites in France from Bertin Pharma with a strong expertise in galenic formulation and development. This acquisition is expected to be closed during the summer.

    Amatsigroup is one of the largest independent multi-specialist platforms in Europe with a unique proposal for specialty and biopharma clients, including biopharmaceutical analysis, formulation development and manufacturing, biological research & development, among other services. The company employs about 450 staff and plans to generate over $65 million in revenues in 2017.

    The CDMO has 8 sites in France, including the sites acquired from Bertin Pharma, 2 sites in Belgium and 1 site in the U.S. The company is organized in five business units and delivers a differentiated specialist offer focused on biotechnology companies and mid-size pharma companies, supported by technical capabilities and project management over the whole development cycle. Given its unique positioning as a high value added multi-specialist drug development services provider, the company is well-positioned to leverage and strengthen its footprint in the CDMO industry.

    “Over the past 6 years, thanks to the support of our shareholder Ekkio Capital, the company has become a leader in its sector,” said Alain Sainsot, managing director, Amatsigroup. “The Eurofins network would now offer us the opportunity to develop our multi-specialist platform proposal in other countries, get access to Eurofins group international clients as well as to Eurofins globally standardized IT and quality management solutions and generally to strengthen our position as a leader in the CDMO sector in France and other parts of Europe.”

    Should the deal come to closing, the addition of Amatsigroup to the Eurofins network would strengthen the Group's biopharma product testing biopharmaceutical service offering, and strengthen its growing presence in the field of formulation, development and manufacturing of new drugs, following the acquisition of Alphora in Canada earlier this year.

    Dr. Gilles Martin, chief executive officer, Eurofins, said, “The acquisition of the Amatsi Group is reinforcing Eurofins leadership position into the BioPharma services line of business. Amatsi’s fast growing contract development and manufacturing services is enabling Eurofins entry in this attractive space in Europe and will be very complementary to our growing network of biopharma product testing activities in Europe. Together with Alphora, recently acquired in Canada, Eurofins is now ready to service its customers on two continents in the CDMO space.”
    Related Searches
    • biotechnology
    • chief executive officer
    • formulation
    • CDMO
    Suggested For You
    Eurofins Scientific Acquires Beacon Discovery Eurofins Scientific Acquires Beacon Discovery
    Vetio Animal Health Vetio Animal Health
    Idifarma Approved for EU-GMP Commercial Capsule Mfg. Idifarma Approved for EU-GMP Commercial Capsule Mfg.
    Eurofins Acquires Alphora Research Eurofins Acquires Alphora Research
    CoreRx, Aimmune Unveil Joint Expansion CoreRx, Aimmune Unveil Joint Expansion
    Newsmakers: Lee Karras Newsmakers: Lee Karras
    Pierre Fabre Buys Igenica Immuno-oncology Assets Pierre Fabre Buys Igenica Immuno-oncology Assets
    UPM Celebrates 100-Years of Mfg. at Tennessee Site UPM Celebrates 100-Years of Mfg. at Tennessee Site
    Thermo Fisher Buys Patheon for $7.2B Thermo Fisher Buys Patheon for $7.2B
    Next-Gen Bioprocessing Next-Gen Bioprocessing
    Eurofins Expands Biopharma Testing Operations Eurofins Expands Biopharma Testing Operations
    Newsmakers: Peter Soelkner Newsmakers: Peter Soelkner
    Solubility Enhancement: Novel Approaches to Rational Formulation Choice Solubility Enhancement: Novel Approaches to Rational Formulation Choice
    API Makers Speed Expansion API Makers Speed Expansion
    Analytical Testing Outsourcing Trends Update Analytical Testing Outsourcing Trends Update

    Related Breaking News

    • Breaking News | CRO News | Industry News
      Eurofins Scientific Acquires Beacon Discovery

      Eurofins Scientific Acquires Beacon Discovery

      Expands its integrated drug discovery capabilities and expertise.
      Charles Sternberg, Assistant Editor 02.19.21

    • Vetio Animal Health

      Vetio Animal Health

      ...
      John Kane, CEO 10.24.19

    • Breaking News | Capsules | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Idifarma Approved for EU-GMP Commercial Capsule Mfg.

      Idifarma Approved for EU-GMP Commercial Capsule Mfg.

      New Bosch GKF-702 automatic capsule filling machine up and running at Pamplona plant
      07.03.17


    • APIs | Bioanalytical Services | Breaking News | Cytotoxics and High Potency Manufacturing | Industry News
      Eurofins Acquires Alphora Research

      Eurofins Acquires Alphora Research

      Expands role in biopharmaceutical services
      06.14.17

    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Facilities | Industry News
      CoreRx, Aimmune Unveil Joint Expansion

      CoreRx, Aimmune Unveil Joint Expansion

      Together will advance treatment of peanut and other food allergies
      06.13.17

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    • Merck KGaA, Quris-AI Expand Collaboration
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Siemens Healthineers’ Magnetom Viato.Mobile Cleared by FDA
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    Sanner Group Opens Second Manufacturing Facility in China
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    Breakfast with Oral Care Benefits?
    Stanford Researchers Study Skin and Sensorial Perception
    L’Oréal Awarded US Patent for Makeup
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login